A Risk Stratification Model for Cardiovascular Complications during the 3-Month Period after Major Elective Vascular Surgery

Table 2

Drugs in patients with and without CV complications.

Therapy	with CV complications		Without CV complications		p^1
	Broj	%	Broj	%
Beta blocker	23	79.3	67	72.0	0.593
ACE inhibitors	24	82.8	62	66.7	0.154
Calcium channel blocker	12	41.4	18	19.8	0.036
Antiaggregation therapy	24	82.8	55	59.1	0.036
Statins	12	41.4	45	48.4	0.655
Diuretics	3	10.3	6	6.5	0.769
Long acting nitrates	2	6.9	2	2.2	0.512

¹Chi-square test.